High Vista Strategies LLC Palatin Technologies Inc Transaction History

High Vista Strategies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$0.75 - $0.89 $43,650 - $51,798	-58,200 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$0.78 - $1.09 $45,396 - $63,438	58,200 New	58,200 $53,000
Q4 2018 Feb 14, 2019	SELL	$0.63 - $1.0 $12,096 - $19,200	-19,200 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$0.88 - $1.1 $16,896 - $21,120	19,200 New	19,200 $19,000

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $7.25M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.